Glycoside-containing liposome

a glycoside and liposome technology, applied in the field of liposomes, can solve the problems of insufficient antitumor effect, and achieve the effects of enhancing the solubility of a glycoside having antitumor activity, potent antitumor activity, and efficiently exhibiting its inherent antitumor

Inactive Publication Date: 2008-12-16
OTSUKA PHARM CO LTD
View PDF9 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0008]An object of the present invention is to provide a drug product which contains a glycoside having antitumor activity, and which enables the glycoside to exhibit its inherent antitumor effects more efficiently.
[0009]In view of the foregoing, the present inventors have conducted extensive studies on administration forms of a glycoside of a hydrophobic compound (hereinafter may be referred to as a “hydrophobic compound glycoside”) having antitumor activity, and as a result have found that when a liposomal composition is prepared from the glycoside together with a membrane component (at least a phospholipid) and a positive-charge-providing substance, the liposomal composition enables use of the glycoside, which has been difficult to use due to its low solubility, and the composition enables the glycoside to more efficiently exhibit its inherent antitumor effects; for example, the composition exhibits potent antitumor activity against such a tumor line that scarcely responds to the antitumor effects of the glycoside when administered as such.
[0014]According to the present invention, the solubility of a glycoside having antitumor activity is enhanced, and there can be provided a drug product which enables the glycoside to more efficiently exhibit its inherent antitumor effects. Particularly, a drug product containing cholestanol glycoside (1) exhibits potent antitumor activity against such a cancer cell line that scarcely responds to the antitumor effects of the glycoside when administered as such; i.e., the drug product can maximize the antitumor effects of the compound.

Problems solved by technology

However, such a glycoside is difficult to use due to its low solubility, and may fail to sufficiently exhibit its effects to some carcinomas.Patent Document 1: JP-A-11-60592Patent Document 2: JP-A-2000-191685

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Glycoside-containing liposome
  • Glycoside-containing liposome
  • Glycoside-containing liposome

Examples

Experimental program
Comparison scheme
Effect test

example 1

Formation of Liposomes from Cholestanol Glycoside

[0064]There were employed, as cholestanol glycosides, “GlcNAcβ1,4GalChol”; i.e., a cholestanol compound of formula (1) in which G is GlcNAcβ1,4Gal, “Fucα1,3GalChol”; i.e., a cholestanol compound of formula (1) in which G is Fucα1,3Gal, and “GalβChol”; i.e., a cholestanol compound of formula (1) in which G is Galβ. For comparison, “Chol”; i.e., a cholestanol compound of formula (1) in which G is H was employed. A 20 μmol / mL solution of each of these compounds (dissolved in chloroform / methanol=5 / 1 (v / v)) was employed as a starting material.

[0065]1α-Dipalmitoylphosphatidylcholine, stearylamine, and each of the aforementioned cholestanol compounds were mixed in proportions of 52 / 8 / 20 (by mole) so as to attain a total amount of 700 μL, and subsequently an organic solvent (chloroform / methanol=2 / 1 (v / v)) (300 μL) and distilled water (1 mL) were added to and mixed with the resultant mixture. Thereafter, the organic solvent was completely remo...

example 2

Formation of Liposomes from Naphthalene Methanol Glycoside

[0066]There was employed, as a naphthalene methanol glycoside, “GlcNAcβ1,4Galβ1,1NM” (NM: naphthalene methanol); i.e., a compound of formula (2) in which G is GlcNacβ1,4-Galβ1,1-, and liposomes were formed from this naphthalene methanol glycoside under conditions similar to those for formation of the cholestanol glycoside liposomes.

example 3

Formation of Liposomes from Ceramide Glycoside

[0067]There was employed, as a ceramide glycoside, “GlcNAcβ1,3Galβ1,4Glcβ1,1Ceramide”; i.e., a compound of formula (3) in which G is GlcNacβ1,3-Galβ1,4-Glc-, and liposomes were formed from this ceramide glycoside in a manner similar to that of formation of the cholestanol glycoside liposomes. In the case of formation of ceramide glycoside liposomes, cholesterol was added as a stabilizer.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to view more

Abstract

A drug product which can maximize the effect of a cholestanol glycoside useful as an anticancer agent. The present invention provides a liposomal composition containing a glycoside exhibiting antitumor activity, a phospholipid, and a positive-charge-providing substance; the glycoside being composed of GlcNAc-Gal-, GlcNAc-Gal-Glc-, Fuc-Gal-, Gal-Glc-, or Gal- as a sugar moiety, and a hydrophobic compound capable of forming a liposome.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]The present application is a 35 U.S.C. § 371 National Stage patent application of International patent application PCT / JP04 / 10103, filed on Jul. 15, 2004, which claims priority to Japanese patent application JP2003-198476, filed on Jul. 13, 2003.TECHNICAL FIELD[0002]The present invention relates to a liposome (hereinafter may be referred to as a “liposomal composition”) containing a glycoside which is useful as an anticancer agent.BACKGROUND ART[0003]Among other cholestanol glycosides, the below-described cholestanol glycoside (1), which is obtained through bonding of a specific sugar chain to cholestanol formed through saturation of the carbon-carbon double bond of the B ring of cholesterol, exhibits the effect of inhibiting growth of cancer cells, and is a compound useful as an anticancer agent (see Patent Documents 1 and 2).[F1][0004][wherein G represents GlcNAc-Gal-, GlcNAc-Gal-Glc-, Fuc-Gal-, Gal-Glc-, or Gal-].[0005]A hydrophobic co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(United States)
IPC IPC(8): A61K31/335A61K9/127A61K31/7032A61K31/704A61P35/00C07H15/10C07H15/18C07J17/00
CPCA61K9/1272A61K31/7032A61K31/704C07H15/10C07H15/18C07J17/00A61P35/00A61K9/127
Inventor YAZAWA, SHINTAKAI, IZUMINISHIMURA, TOUYOU
Owner OTSUKA PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap